ESMO 2022 Conference Coverage


 

ESMO 2022 on the DAISY Trial: Antitumor Activity of T-DXd in Patients With mBC and Brain Metastases

1,300 views
September 14, 2022
Comments 0
Login to view comments. Click here to Login